Arbutus to Report Second Quarter 2021 Financial Results and Provide Corporate Update
July 29 2021 - 8:00AM
Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage
biopharmaceutical company primarily focused on discovering,
developing and commercializing a cure for people with chronic
hepatitis B virus (HBV) infection, as well as therapies to treat
coronaviruses (including COVID-19), today announced that it has
scheduled its second quarter 2021 financial results and corporate
update for Thursday, August 5, 2021. The schedule for the press
release and conference call/webcast are as follows:
• |
2Q/2021 Press Release: |
Thursday, August 5, 2021 at 7:30 a.m. ET |
• |
2Q/2021 Conference Call/Webcast: |
Thursday, August 5, 2021 at 8:45 a.m. ET |
• |
Domestic Dial-In Number: |
(866) 393-1607 |
• |
International Dial-In Number: |
(914) 495-8556 |
• |
Conference ID Number: |
2719108 |
A live webcast of the conference call can be
accessed through the Investors section of Arbutus' website at
www.arbutusbio.com or directly at Live Webcast.
An archived webcast will be available on the
Arbutus website after the event. Alternatively, you may access a
replay of the conference call by calling (855) 859-2056 or (404)
537-3406, and reference conference ID: 2719108.
About Arbutus
Arbutus Biopharma Corporation is a publicly
traded (Nasdaq: ABUS) biopharmaceutical company primarily focused
on discovering, developing and commercializing a cure for people
with chronic hepatitis B virus (HBV) infection. The Company is
advancing multiple product candidates with distinct mechanisms of
action that it believes have the potential to provide a new
curative regimen for chronic HBV infection. Arbutus has also
initiated a drug discovery and development effort for treating
coronaviruses (including COVID-19). For more information, visit
www.arbutusbio.com.
Contact Information
Investors and Media
William H. CollierPresident and CEO Phone: 267-469-0914Email:
ir@arbutusbio.comPam MurphyInvestor Relations ConsultantPhone:
267-469-0914Email: ir@arbutusbio.com
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Sep 2023 to Sep 2024